MITCHELL FRIEDMAN: Open Payments
NPI 1851061808 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 10 payments from 8 companies in 2025. Trend: 2023 $39 · 2024 $250 · 2025 $310
Food & beverage: $278Education: $32
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $79 |
| Baxter Healthcare | 1 | $78 |
| Novo Nordisk Inc | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| MEDICOMP INC | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
Products named: Hillrom - Carnation Ambulatory Monitor, VYNDAQEL, Ozempic, LEQVIO, ELIQUIS, TELEPATCH CARDIAC MONITOR, CAMZYOS, Attruby.
Industry payments across CT — which companies pay providers there.
